Results 81 to 90 of about 16,837 (286)
Evidence for a regulatory idiotypic network in the in vivo response to H-2 antigens. [PDF]
Treatment of BALB/c mice with purified pig antiidiotype to 11-4.1 (anti-H-2Kk) monoclonal antibody has been found previously to induce the appearance of idiotype-bearing molecules (Id') in the serum of these mice, in the absence of detectable antigen ...
Bluestone, JA, Rabinowitz, R, Sachs, DH
core
Neonatal alloimmune thrombocytopenia
Neonatal alloimmune thrombocytopenia is the commonest cause of early onset isolated thrombocytopenia in an otherwise healthy neonate.[1][1] This syndrome is comparable to hemolytic disease of the newborn, although it frequently affects the first infant.
openaire +3 more sources
Non-immune fetal hydrops: etiology and outcome according to gestational age at diagnosis. [PDF]
OBJECTIVE: Fetal hydrops is associated with increased perinatal morbidity and mortality. The etiology and outcome of fetal hydrops may differ according to the gestational age at diagnosis.
A. Bhide+12 more
core +2 more sources
Neonatal alloimmune thrombocytopenia
Neonatal alloimmune thrombocytopenia—caused by movement of maternal alloantibodies directed against fetal platelet antigens across the placenta—is the most common cause of severe neonatal thrombocytopenia.1 These alloantibodies cause thrombocytopenia, which may result in intracranial haemorrhage.2 3 Most cases arise unexpectedly, and prompt diagnosis ...
H Yarranton+6 more
openaire +4 more sources
Background: Red blood cell (RBC) alloimmunization is an immune response against foreign RBC antigens; this generally occurs after sensitization due to multiple blood transfusions and pregnancies.
Anjali Handa+4 more
semanticscholar +1 more source
Granulocyte transfusions in children and adults with hematological malignancies: benefits and controversies [PDF]
Bacterial and fungal infections continue to pose a major clinical challenge in patients with prolonged severe neutropenia after chemotherapy or hematopoietic stem cell transplantation (HSCT).
Cugno, C+4 more
core +1 more source
Yona Mbalibulha,1 Bernard Natukunda,1 Andrew Livex Okwi,2 Joan N Kalyango,3 Kajja Isaac,4 Sam Ononge5 1Department of Medical Laboratory Science, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda; 2Department of Pathology,
Mbalibulha Y+5 more
doaj
Objective: Fetal hemolytic disease is a common cause of fetal hydrops and fetal morbidity and mortality. Despite its relatively low frequency, the anti-M IgG antibody is one of the causes of severe fetal anemia and intrauterine death; only a few cases ...
Lin Li+4 more
doaj +1 more source
Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study [PDF]
ObjectiveTo determine the incidence and risk factors for neurodevelopmental impairment (NDI) in children with hemolytic disease of the fetus/newborn treated with intrauterine transfusion (IUT).Study DesignNeurodevelopmental outcome in children at least 2
Brand, Anneke+13 more
core +1 more source
Red cell alloimmunization in multitransfused hepatobiliary patients at hospital Selayang
BACKGROUND: Transfusion support is vital for the management of patients with hepatobiliary disease. Repeated blood transfusions increase the risk of alloimmunization, i.e., the development of alloantibodies, which might lead to difficulties in blood ...
Prasanthini Nahendran+5 more
doaj +1 more source